Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhalation formulations of Treprostinil

Inhalation formulations of Treprostinil

US Patent 10076505 · Granted Sep 18, 2018

Estimated economic value: $20,093,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Medical body shield2025
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2025
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2025
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2023
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2023
Treatment of pulmonary arterial hypertension with mesenchymal stem cells2023
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2021
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2020
Inhalation formulations of treprostinil2020
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2018
Treatment of pulmonary arterial hypertension with mesenchymal stem cells2018
Treatment of pulmonary arterial hypertension with prostacyclin-treated endotheli2018